Track the 녹십자엠에스 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 녹십자엠에스 has published 4 reports. The latest transaction was reported on 1 July 2026 (Purchase). Among the most active insiders: 김연근. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
녹십자엠에스是一家在XKRX市场上市的健康和制药领域的公司。它专注于药品和医疗设备的开发和分销。